Novo Holdings
Edit

Novo Holdings

https://www.novoholdings.dk
Last activity: 18.07.2024
Active
Novo Holdings A/S, a private limited liability company fully owned by the Novo Nordisk Foundation, is the holding company in the Novo Group, and responsible for managing the Foundation’s assets.

Besides being the major shareholder in the Novo Group companies Novo Nordisk A/S, Novozymes A/S and NNIT A/S, Novo Holdings provides seed and venture capital to development stage companies and takes significant ownership positions in well-established companies within life science, as well as manages a broad portfolio of financial assets.

Follow us on Twitter: https://twitter.com/NovoHoldings
Portfolio
12
Mentions
101
Location: Denmark, Capital Region of Denmark, Gentofte Municipality
Employees: 51-200
Founded date: 1999
Investment Type: Venture Capital
Investment Stage: Series A; Series B

Portfolio 12

DateNameWebsiteTotal RaisedLocation
09.08.2023Bactolifebactolife.com$38.02MDenmark, N...
15.03.2023Clever Car...clevercarehealthplan.com$62MUnited Sta...
09.01.2023Amolyt Pha...amolytpharma.com$218MFrance, Au...
09.01.2023Evosep Bio...evosep.com$40MDenmark
07.11.2022Roslin Tec...roslintech.com$12.61MUnited Kin...
12.05.2022Nuvig Ther...nuvigtherapeutics.com$47MUnited Sta...
22.07.2021Hemab Ther...hemab.com$190MDenmark, C...
27.05.2021Escoescolifesciences.com$200MUnited Sta...
29.04.2021adcendoadcendo.com$226.66MDenmark, C...
03.11.2020The Protei...theproteinbrewery.nl$26M-
Show more

Mentions in press and media 101

DateTitleDescription
18.07.2024Asceneuron's $100M Series C Funding Boosts Alzheimer's Disease ResearchAsceneuron, a Lausanne-based clinical-stage biotech company, has recently announced the successful completion of a $100 million Series C financing round. This significant funding boost, led by Novo Holdings and supported by EQT Life Science...
16.07.2024Asceneuron closes $100 million series C financing round Asceneuron SA, a Lausanne-based clinical-stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, announces its $100 million oversubscribed Series C financing round. The...
16.07.2024EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing roundEQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round Tue, Jul 16, 2024 09:15 CET Report this content EQT Life Sciences has invested in Asceneuron’s oversubscr...
15.07.2024Temasek aims to invest up to $10 bn in India over three yearsCredit: Reuters Singapore state investor Temasek plans to invest up to $10 billion in India over three years in sectors such as financial services and healthcare, a top executive said on Monday, favouring the South Asian nation as it turns ...
10.07.2024Future Food Quick Bites: Crownless Pineapples, Spent Coffee Cookies & A Brat Summer6 Mins Read In our weekly column, we round up the latest news and developments in the alternative protein and sustainable food industry. This week, Future Food Quick Bites covers Aldi’s zero-waste pineapples, a Charli XCX-inspired marketing...
03.07.2024Novo Holdings Invests in MATR Foods’ Fungi-Powered Fermented Meat AlternativesLife science investor Novo Holdings has announced an initial investment in MATR Foods, a Danish food tech startup leveraging the power of mycelium, traditional fermentation, and upcycled vegetables to make sustainable meat alternative produ...
02.07.2024AI-based agritech firm AgNext Technologies receives investment from NovoNovo Holdings, an investor based in Denmark, revealed that it had taken the lead in funding AgNext Technologies Private Limited, an agricultural and food technology company based in India that innovates artificial intelligence-based technol...
25.06.2024Novo Holdings invests in Indian agritech firm AgNext TechnologiesCopenhagen-based life sciences investor Novo Holdings has invested an undisclosed sum in Indian agritech player AgNext Technologies Private Limited to support the latter’s growth and international expansion. The deal marks Novo Holdings’s f...
25.06.2024Healthcare-focussed Novo Holdings bets on homegrown agritech firmPremium Kasim Kutay, CEO, Novo Holdings | Credit: Reuters/Ali Withers Danish investor Novo Holdings, which has primarily invested in healthcare companies in India and owns a majority stake in weight-loss drugmaker Novo Nordisk, has invested...
14.06.2024Ex-Groupon CEO raises $411 million in IPO for medicine data companyfigcaption>span]:font-sans" data-chromatic="ignore"> Tempus AI, a Chicago-based provider of data and analytics tools for precision medicine developers, raised $411 million in its IPO. Why it matters: You probably didn't...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In